Correlation Between Medigen Biotechnology and Chien Kuo

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Medigen Biotechnology and Chien Kuo at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Medigen Biotechnology and Chien Kuo into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Medigen Biotechnology and Chien Kuo Construction, you can compare the effects of market volatilities on Medigen Biotechnology and Chien Kuo and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Medigen Biotechnology with a short position of Chien Kuo. Check out your portfolio center. Please also check ongoing floating volatility patterns of Medigen Biotechnology and Chien Kuo.

Diversification Opportunities for Medigen Biotechnology and Chien Kuo

-0.76
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Medigen and Chien is -0.76. Overlapping area represents the amount of risk that can be diversified away by holding Medigen Biotechnology and Chien Kuo Construction in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Chien Kuo Construction and Medigen Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Medigen Biotechnology are associated (or correlated) with Chien Kuo. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Chien Kuo Construction has no effect on the direction of Medigen Biotechnology i.e., Medigen Biotechnology and Chien Kuo go up and down completely randomly.

Pair Corralation between Medigen Biotechnology and Chien Kuo

Assuming the 90 days trading horizon Medigen Biotechnology is expected to under-perform the Chien Kuo. In addition to that, Medigen Biotechnology is 1.18 times more volatile than Chien Kuo Construction. It trades about -0.17 of its total potential returns per unit of risk. Chien Kuo Construction is currently generating about 0.0 per unit of volatility. If you would invest  2,710  in Chien Kuo Construction on September 20, 2024 and sell it today you would lose (10.00) from holding Chien Kuo Construction or give up 0.37% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Medigen Biotechnology  vs.  Chien Kuo Construction

 Performance 
       Timeline  
Medigen Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Medigen Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.
Chien Kuo Construction 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Chien Kuo Construction are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Chien Kuo showed solid returns over the last few months and may actually be approaching a breakup point.

Medigen Biotechnology and Chien Kuo Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Medigen Biotechnology and Chien Kuo

The main advantage of trading using opposite Medigen Biotechnology and Chien Kuo positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Medigen Biotechnology position performs unexpectedly, Chien Kuo can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chien Kuo will offset losses from the drop in Chien Kuo's long position.
The idea behind Medigen Biotechnology and Chien Kuo Construction pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Complementary Tools

Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes